• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

需要持续肾脏替代治疗的先天性肾衰竭新生儿的生长情况。

Growth in neonates with congenital kidney failure requiring continuous kidney replacement therapy.

作者信息

Short Kara, Hanick Janelle, Bickert Perrin, Potts Jessica, Askenazi David

机构信息

Children's of Alabama, Birmingham, USA.

Pediatric and Infant Center for Acute Nephrology, Children's of Alabama and University of Alabama at Birmingham, Birmingham, USA.

出版信息

Pediatr Nephrol. 2025 Aug 7. doi: 10.1007/s00467-025-06887-y.

DOI:10.1007/s00467-025-06887-y
PMID:40775407
Abstract

BACKGROUND

With advanced technology, survival of neonates with congenital kidney failure (CKF) requiring continuous kidney replacement therapy (CKRT) has improved. Nutrition is essential but difficult to attain as CKRT removes proteins and micronutrients, and many patients have multiple co-morbidities. Scant data exist to guide clinicians on appropriate energy requirements for growth.

METHODS

We performed a retrospective study of neonates with CKF admitted to Children's of Alabama between 2016 and 2022 who required KRT within 10 days. We evaluated risk factors and growth in the 18/24 (75%) infants who survived to 90 days. Our primary and secondary outcomes were length z-score ≥  - 2 vs. <  - 2 at 90 days and weight z-score ≥  - 2 vs. <  - 2 at 90 days, respectively. Demographics, comorbidities, CKRT Dose Eras (1-body surface area (2000/1.73/m/hr) vs. 2-weight-based era (24 ml/kg/hr)), and Nutrition Era 1 vs. 2 were evaluated.

RESULTS

At 90 days, 7/18 (38.9%) had length z-score ≥  - 2 while 10/18 (55.6%) had a weight z-score ≥  - 2. Factors for weight z-score ≥  - 2 include time to PD transition and CKRT Dose Era 2. Factors for length z-score ≥  - 2 included Era with higher calorie and protein goal targets (both p < 0.01).

CONCLUSIONS

Malnutrition in neonates with CKF on CKRT is high. More studies are needed to better understand optimal strategies to ensure adequate growth. Until then, we recommend 24 ml/kg/hr clearance dose and prescribing at least 130 kcal/kg/day and 4 g/kg/day amino acids to target higher actual intake to start for these patients.

摘要

背景

随着技术的进步,需要持续肾脏替代治疗(CKRT)的先天性肾衰竭(CKF)新生儿的存活率有所提高。营养至关重要,但由于CKRT会清除蛋白质和微量营养素,且许多患者有多种合并症,因此难以实现。目前几乎没有数据可指导临床医生确定适合生长的能量需求。

方法

我们对2016年至2022年期间入住阿拉巴马州儿童医院且在10天内需要进行肾脏替代治疗(KRT)的CKF新生儿进行了一项回顾性研究。我们评估了18/24(75%)存活至90天的婴儿的风险因素和生长情况。我们的主要和次要结局分别是90天时身长z评分≥ -2与< -2,以及90天时体重z评分≥ -2与< -2。评估了人口统计学、合并症、CKRT剂量时代(1-体表面积(2000/1.73/m/hr)与2-体重计算时代(24 ml/kg/hr))以及营养时代1与2。

结果

90天时,7/18(38.9%)的身长z评分≥ -2,而10/18(55.6%)的体重z评分≥ -2。体重z评分≥ -2的因素包括开始腹膜透析(PD)转换的时间和CKRT剂量时代2。身长z评分≥ -2的因素包括卡路里和蛋白质目标更高的时代(两者p<0.01)。

结论

接受CKRT的CKF新生儿营养不良的发生率很高。需要更多研究来更好地理解确保充足生长的最佳策略。在此之前,我们建议这些患者的清除剂量为24 ml/kg/hr,并规定至少130 kcal/kg/天和4 g/kg/天的氨基酸,以实现更高的实际摄入量。

相似文献

1
Growth in neonates with congenital kidney failure requiring continuous kidney replacement therapy.需要持续肾脏替代治疗的先天性肾衰竭新生儿的生长情况。
Pediatr Nephrol. 2025 Aug 7. doi: 10.1007/s00467-025-06887-y.
2
Higher versus lower amino acid intake in parenteral nutrition for newborn infants.新生儿肠外营养中较高与较低氨基酸摄入量的比较。
Cochrane Database Syst Rev. 2018 Mar 5;3(3):CD005949. doi: 10.1002/14651858.CD005949.pub2.
3
Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome.全身性治疗史蒂文斯-约翰逊综合征(SJS)、中毒性表皮坏死松解症(TEN)和 SJS/TEN 重叠综合征。
Cochrane Database Syst Rev. 2022 Mar 11;3(3):CD013130. doi: 10.1002/14651858.CD013130.pub2.
4
Corticosteroids for the treatment of Duchenne muscular dystrophy.用于治疗杜氏肌营养不良症的皮质类固醇
Cochrane Database Syst Rev. 2016 May 5;2016(5):CD003725. doi: 10.1002/14651858.CD003725.pub4.
5
Protein restriction for diabetic kidney disease.限制蛋白质摄入治疗糖尿病肾病。
Cochrane Database Syst Rev. 2023 Jan 3;1(1):CD014906. doi: 10.1002/14651858.CD014906.pub2.
6
The risks, benefits, and resource implications of different diets in gastrostomy-fed children: The YourTube mixed method study.胃造口喂养儿童不同饮食的风险、益处及资源影响:YouTube混合方法研究
Health Technol Assess. 2025 Jul;29(25):1-21. doi: 10.3310/RRREF7741.
7
Non-pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy.非药物干预措施预防连续性肾脏替代治疗中体外循环凝血。
Cochrane Database Syst Rev. 2021 Sep 14;9(9):CD013330. doi: 10.1002/14651858.CD013330.pub2.
8
Pharmacological treatment of gastro-oesophageal reflux in children.儿童胃食管反流病的药物治疗。
Cochrane Database Syst Rev. 2023 Aug 22;8(8):CD008550. doi: 10.1002/14651858.CD008550.pub3.
9
The role of a "volume sparing" strategy in kidney replacement therapy of AKI: a retrospective single-center study.“容量节约”策略在急性肾损伤肾脏替代治疗中的作用:一项回顾性单中心研究。
J Nephrol. 2025 Jan;38(1):235-241. doi: 10.1007/s40620-024-02142-z. Epub 2025 Jan 9.
10
Inborn errors of metabolism in neonates and pediatrics on varying dialysis modalities: a systematic review and meta-analysis.新生儿及儿科不同透析方式下的先天性代谢缺陷:一项系统评价与荟萃分析
Pediatr Nephrol. 2024 Nov 11. doi: 10.1007/s00467-024-06547-7.

本文引用的文献

1
Research progress on nutritional support in the neonatal and pediatric populations receiving extracorporeal membrane oxygenation.接受体外膜肺氧合治疗的新生儿和儿科人群营养支持的研究进展
Front Nutr. 2024 Jun 3;11:1370286. doi: 10.3389/fnut.2024.1370286. eCollection 2024.
2
Clearance and nutrition in neonatal continuous kidney replacement therapy using the Carpediem™ system.使用 Carpediem™ 系统进行新生儿连续性肾脏替代治疗的清除率和营养。
Pediatr Nephrol. 2024 Jun;39(6):1937-1950. doi: 10.1007/s00467-023-06237-w. Epub 2024 Jan 17.
3
Optimizing Nutrition in Neonates with Kidney Dysfunction.
优化肾功能不全新生儿的营养。
Neoreviews. 2024 Jan 1;25(1):e25-e35. doi: 10.1542/neo.25-1-e25.
4
Nutrition for critically ill children and neonates requiring dialysis: Application of clinical practice recommendations.危重症儿童和需要透析的新生儿的营养:临床实践建议的应用。
Nutr Clin Pract. 2023 Oct;38 Suppl 2:S139-S157. doi: 10.1002/ncp.11048.
5
Worldwide Exploration of Renal Replacement Outcomes Collaborative in Kidney Disease (WE-ROCK).全球肾脏疾病肾脏替代治疗结局协作组(WE-ROCK)。
Kidney Int Rep. 2023 Jun 5;8(8):1542-1552. doi: 10.1016/j.ekir.2023.05.026. eCollection 2023 Aug.
6
Fetal interventions for congenital renal anomalies.先天性肾脏异常的胎儿干预措施。
Transl Pediatr. 2021 May;10(5):1506-1517. doi: 10.21037/tp-2020-fs-05.
7
Nutrition Considerations in Neonatal Extracorporeal Life Support.新生儿体外生命支持中的营养考量
Neoreviews. 2021 Jun;22(6):e382-e391. doi: 10.1542/neo.22-6-e382.
8
KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update.KDIGO 临床实践指南:慢性肾脏病中的营养治疗 2020 年更新版。
Am J Kidney Dis. 2020 Sep;76(3 Suppl 1):S1-S107. doi: 10.1053/j.ajkd.2020.05.006.
9
Energy and protein requirements for children with CKD stages 2-5 and on dialysis-clinical practice recommendations from the Pediatric Renal Nutrition Taskforce.能量和蛋白质需求的儿童慢性肾脏病 2-5 期和透析-临床实践建议的儿科肾脏营养工作组。
Pediatr Nephrol. 2020 Mar;35(3):519-531. doi: 10.1007/s00467-019-04426-0. Epub 2019 Dec 16.
10
End-stage kidney disease in infancy: an educational review.婴儿期终末期肾病:教育综述。
Pediatr Nephrol. 2020 Feb;35(2):229-240. doi: 10.1007/s00467-018-4151-8. Epub 2018 Nov 21.